MXPA04001631A - Resolucion enzimatica de derivados de taxano de t-butilo. - Google Patents

Resolucion enzimatica de derivados de taxano de t-butilo.

Info

Publication number
MXPA04001631A
MXPA04001631A MXPA04001631A MXPA04001631A MXPA04001631A MX PA04001631 A MXPA04001631 A MX PA04001631A MX PA04001631 A MXPA04001631 A MX PA04001631A MX PA04001631 A MXPA04001631 A MX PA04001631A MX PA04001631 A MXPA04001631 A MX PA04001631A
Authority
MX
Mexico
Prior art keywords
butyl
mixture
enzymatic resolution
taxane derivatives
enantiomers
Prior art date
Application number
MXPA04001631A
Other languages
English (en)
Inventor
N Patel Ramesh
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MXPA04001631A publication Critical patent/MXPA04001631A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un metodo para la resolucion de una mezcla de enantiomeros cis o trans de la formula (I) en donde R1 es -O-C(O) alquilo, -O-C-(O) arilo o -O-C(O)-cicloalquilo poniendo en contacto una mezcla con una enzima hidrolasa de ester carboxilico la cual cataliza la hidrolisis estereoselectiva de una mezcla y el uso de tales enantiomeros para producir compuestos antitumorales, los cuales son especialmente adecuados para administracion oral.
MXPA04001631A 2001-08-21 2002-08-21 Resolucion enzimatica de derivados de taxano de t-butilo. MXPA04001631A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31375701P 2001-08-21 2001-08-21
PCT/US2002/026810 WO2003016543A2 (en) 2001-08-21 2002-08-21 Enzymatic resolution of t-butyl taxane derivatives

Publications (1)

Publication Number Publication Date
MXPA04001631A true MXPA04001631A (es) 2004-07-08

Family

ID=23217015

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001631A MXPA04001631A (es) 2001-08-21 2002-08-21 Resolucion enzimatica de derivados de taxano de t-butilo.

Country Status (13)

Country Link
US (1) US7063977B2 (es)
EP (1) EP1425407A4 (es)
JP (1) JP2007503201A (es)
KR (1) KR20040053114A (es)
CN (1) CN1294274C (es)
AU (1) AU2002323346B2 (es)
BR (1) BR0211999A (es)
CZ (1) CZ2004254A3 (es)
HU (1) HUP0500645A3 (es)
IL (1) IL160061A0 (es)
MX (1) MXPA04001631A (es)
PL (1) PL374278A1 (es)
WO (1) WO2003016543A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108084126A (zh) * 2016-11-21 2018-05-29 山东国际生物科技园发展有限公司 化合物FuramycinsⅠ和Ⅱ及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MY110249A (en) * 1989-05-31 1998-03-31 Univ Florida State Method for preparation of taxol using beta lactam
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5284864A (en) * 1991-09-23 1994-02-08 Florida State University Butenyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5274124A (en) * 1991-09-23 1993-12-28 Florida State University Metal alkoxides
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides
ES2149800T3 (es) * 1992-01-15 2000-11-16 Squibb & Sons Inc Procedimientos enzimaticos para la resolucion de mezclas enantiomericas de compuestos utiles como intermediarios en la preparacion de taxanos.
US5939561A (en) * 1992-03-10 1999-08-17 Rhone-Poulence Rorer S.A. Process for the preparation of β-phenylisoserine and β-lactam and their analogues
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
CA2100808A1 (en) 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
US5420337A (en) * 1992-11-12 1995-05-30 E. R. Squibb & Sons, Inc. Enzymatic reduction method for the preparation of compounds useful for preparing taxanes
US5973160A (en) * 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
RU2125042C1 (ru) 1992-12-23 1999-01-20 Бристоль-Мейерз Сквибб Компани Таксаны с боковой цепью, промежуточные соединения, способы получения
US5840929A (en) * 1995-04-14 1998-11-24 Bristol-Myers Squibb Company C4 methoxy ether derivatives of paclitaxel
TW354293B (en) 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
UA74767C2 (en) 1997-05-27 2006-02-15 Baker Norton Pharma Method and composition for oral use of taxanes in patients
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6916942B2 (en) * 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US20050020685A1 (en) * 2003-06-12 2005-01-27 Skonezny Paul M. Process for recovery of 6-aminopenicillanic acid from an aqueous discharge stream

Also Published As

Publication number Publication date
CZ2004254A3 (cs) 2004-10-13
IL160061A0 (en) 2004-06-20
WO2003016543A2 (en) 2003-02-27
HUP0500645A2 (hu) 2005-09-28
EP1425407A2 (en) 2004-06-09
PL374278A1 (en) 2005-10-03
JP2007503201A (ja) 2007-02-22
AU2002323346B2 (en) 2007-09-20
US20030069415A1 (en) 2003-04-10
WO2003016543A3 (en) 2003-07-24
US7063977B2 (en) 2006-06-20
EP1425407A4 (en) 2007-02-21
HUP0500645A3 (en) 2009-03-02
KR20040053114A (ko) 2004-06-23
BR0211999A (pt) 2005-08-02
CN1294274C (zh) 2007-01-10
CN1545555A (zh) 2004-11-10

Similar Documents

Publication Publication Date Title
WO2002066667A8 (en) Glucosamine and method of making glucosamine from microbial biomass
Hughes et al. Lipase-catalyzed asymmetric hydrolysis of esters having remote chiral/prochiral centers
KR100216011B1 (ko) 광학활성의중간체및그의제조방법
Arroyo et al. Biocatalysis for industrial production of active pharmaceutical ingredients (APIs)
AU2002339838A1 (en) Azeotropic distillation of cyclic esters of hydroxy organic acids
Elson et al. The identification of three new biosynthetic intermediates and one further biosynthetic enzyme in the clavulanic acid pathway
MXPA04001631A (es) Resolucion enzimatica de derivados de taxano de t-butilo.
Shioji et al. Synthesis of bifunctional P-chiral hydroxy phosphinates; lipase-catalyzed stereoselective acylation of ethyl (1-hydroxyalkyl) phenylphosphinates
AU2003222709A1 (en) Plating media
Majewska et al. Simple and effective method for the deracemization of ethyl 1-hydroxyphosphinate using biocatalysts with lipolytic activity
EP0927755A3 (en) Haloaccloacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme
HUP9801621A2 (hu) Új eszteráz és eljárás optikailag aktív chromanvegyületek előállítására
SG120094A1 (en) Process for the enzymatic preparation of enantiomerically enriched beta-amino acids
AU3610299A (en) Novel method for preparing synthesis intermediates
EP0997534A3 (de) Verfahren zur Racematspaltung von Arylalkylcarbonsäureestern
KR940021737A (ko) 2- 피페리딘카르복실산알킬의 효소학적분할 및 획득된 화합물의 합성중간 생성물로서의 사용
HUP0003857A2 (hu) Eljárás alkoxi-furanon-amin-származékok előállítására, az eljárással kapott vegyületek és a vegyületek alkalmazása
Jones et al. An esterase with β-lactamase activity
Gruber-Khadjawi et al. Chemoenzymatic methods for the preparation of optically active cyclic polyazido alcohols from easily available achiral starting materials
TW200505925A (en) Process for synthesizing β-lactamase inhibitor intermediates
ATE386132T1 (de) Verfahren zur enantioselektiven öffnung von 3- substituierten oxetan-2-onen unter verwendung der lipasen von candida antarctica oder von burkholderia plantarii
HK1063819A1 (en) Process for preparation of optically active propoxyaniline derivatives
HUP9903899A2 (hu) Eljárás L-aminosavak fermentációs előállítására
Chĕnevert et al. Enantioselective hydrolysis of (±)-chloramphenicol palmitate by hydrolases
WO2002061094A3 (de) Mikrobiologisches verfahren zur herstellung von l-carnitin